Background & Aims

Antagonists of TRPV1 that inhibit all activation modes cause hyperthermia, hampering their medical use as novel analgesics. TRPV1 antagonists that do not (fully) inhibit responses to low pH do not cause hyperthermia, but it remains incompletely understood how such antagonists affect channel gating. We tested the hypothesis that pH-sparing antagonists act in a modality-selective manner on TRPV1, differentially affecting channel activation by protons and capsaicin.

Methods

Using whole-cell patch-clamp and calcium imaging to measure channel activity in cells expressing wild type human TRPV1 or the pH-insensitive mutant F660A. Responses to protons and capsaicin were measured at different pH values in the presence of antagonists that reportedly partially spare (A-1165442) or potentiate (AMG7905) acid-evoked channel activation.

Results

At pH 5.5, A-1165442 was equipotent at blocking acid- and capsaicin-evoked responses of wild type TRPV1. Its potency to inhibit acid-evoked responses was attenuated at pH???5.0. AMG7905, at a concentration (1 ?M) that fully inhibits capsaicin-evoked responses, potentiated proton-evoked (pH 5.5) responses of wild type TRPV1. In the F660A mutant, the inhibitory efficacy of A-1165442 and AMG7905 towards capsaicin-evoked responses was reduced at lower pH values and AMG7905 acted as a partial agonist.

Conclusions

Our findings show that A-1165442 and AMG7905 interact in a pH-dependent manner with TRPV1, but this pH dependence is not strictly modality-selective. Reduced TRPV1 antagonism at acidic pH may limit analgesic efficacy in injured tissue and needs to be considered in models explaining the effects of antagonists on core body temperature.

References

1. Bamps, D., Vriens, J., de Hoon, J., & Voets, T. (2021). TRP channel cooperation for nociception: Therapeutic opportunities. Annual Review of Pharmacology and Toxicology, 61, 655–677. https://doi.org/10.1146/annurev-pharmtox-010919-023238
2. Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997). The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature, 389, 816–824. https://doi.org/10.1038/39807
3. Davis, J. B., Gray, J., Gunthorpe, M. J., Hatcher, J. P., Davey, P. T., Overend, P., Harries, M. H., Latcham, J., Clapham, C., Atkinson, K., Hughes, S. A., Rance, K., Grau, E., Harper, A. J., Pugh, P. L., Rogers, D. C., Bingham, S., Randall, A., & Sheardown, S. A. (2000). Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature, 405, 183–187. https://doi.org/10.1038/35012076
4. Garami, A., Pakai, E., McDonald, H. A., Reilly, R. M., Gomtsyan, A., Corrigan, J. J., Pinter, E., Zhu, D. X. D., Lehto, S. G., Gavva, N. R., Kym, P. R., & Romanovsky, A. A. (2018). TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: Compounds’ pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development. Acta Physiologica (Oxford, England), 223, e13038. https://doi.org/10.1111/apha.13038
5. Garami, A., Shimansky, Y. P., Pakai, E., Oliveira, D. L., Gavva, N. R., & Romanovsky, A. A. (2010). Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia. The Journal of Neuroscience, 30, 1435–1440. https://doi.org/10.1523/JNEUROSCI.5150-09.2010
6. Gavva, N. R., Bannon, A. W., Surapaneni, S., Hovland, D. N. Jr., Lehto, S. G., Gore, A., Juan, T., Deng, H., Han, B., Klionsky, L., Kuang, R., le, A., Tamir, R., Wang, J., Youngblood, B., Zhu, D., Norman, M. H., Magal, E., Treanor, J. J. S., & Louis, J. C. (2007). The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. The Journal of Neuroscience, 27, 3366–3374. https://doi.org/10.1523/JNEUROSCI.4833-06.2007
7. Gavva, N. R., Treanor, J. J., Garami, A., Fang, L., Surapaneni, S., Akrami, A., Alvarez, F., Bak, A., Darling, M., Gore, A., Jang, G. R., Kesslak, J. P., Ni, L., Norman, M. H., Palluconi, G., Rose, M. J., Salfi, M., Tan, E., Romanovsky, A. A., … Davar, G. (2008). Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain, 136, 202–210. https://doi.org/10.1016/j.pain.2008.01.024
8. Reilly, R. M., McDonald, H. A., Puttfarcken, P. S., Joshi, S. K., Lewis, L., Pai, M., Franklin, P. H., Segreti, J. A., Neelands, T. R., Han, P., Chen, J., Mantyh, P. W., Ghilardi, J. R., Turner, T. M., Voight, E. A., Daanen, J. F., Schmidt, R. G., Gomtsyan, A., Kort, M. E., … Kym, P. R. (2012). Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature. The Journal of Pharmacology and Experimental Therapeutics, 342, 416–428. https://doi.org/10.1124/jpet.111.190314

Presenting Author

Jan Daniluk

Poster Authors

Jan Daniluk

MSc

KU Leuven

Lead Author

E-mail

Topics

  • Mechanisms: Biological-Molecular and Cell Biology